{
    "Trade/Device Name(s)": [
        "RCRP Flex reagent cartridge",
        "Dimension RCRP Flex reagent cartridge assay"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K221119",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003419"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DCN"
    ],
    "Summary Letter Date": "March 17, 2023",
    "Summary Letter Received Date": "January 23, 2023",
    "Submission Date": "January 20, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.5270"
    ],
    "Regulation Name(s)": [
        "C-Reactive Protein Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "C-Reactive Protein (CRP)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (Lithium Heparin)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension clinical chemistry system",
        "Dimension RXL system"
    ],
    "Method(s)/Technology(ies)": [
        "Particle enhanced turbidimetric immunoassay (PETIA)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens Dimension RCRP Flex reagent cartridge assay for quantitative determination of C-Reactive Protein in human serum and lithium heparin plasma using PETIA technology.",
    "Indications for Use Summary": "Intended for quantitative determination of C-Reactive Protein in human serum and plasma (lithium heparin) to aid in detection and evaluation of infection, tissue injury, inflammatory disorders, and associated diseases.",
    "fda_folder": "Immunology"
}